homocysteine has been researched along with Sepsis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Meng, W; Tian, W | 1 |
| Bigler, L; Blom, H; Linnebank, M; Prost, JC; Semmler, A; Smith, D; Smulders, Y | 1 |
| Barr, JW; Berghoff, N; Black, DM; Fosgate, GT; Patterson, BE; Steiner, JM; Suchodolski, JS | 1 |
| Apostolakos, MJ; Arning, E; Bottiglieri, T; Doolin, KP; Gough, MS; Mack, CM; Mooney, RA; Morgan, MAM; Pietropaoli, AP; Wexler, O | 1 |
| Bugyi, B; Horváth-Szalai, Z; Kőszegi, T; Kustán, P; Ludány, A; Mühl, D | 1 |
| Blom, H; Linnebank, M; Moskau, S; Semmler, A; Smith, D; Smulders, Y; Struys, E | 1 |
| Antonakos, G; Armaganidis, A; Bagos, P; Dima, K; Dimopoulou, I; Kapsimali, V; Kopterides, P; Nikolopoulos, G; Travlou, A; Tsangaris, I; Tsantes, A; Vrioni, G | 1 |
| Beutel, G; Cassidy, J; Chick, J; Gill, S; Glen, H; Schöffski, P; Twelves, C | 1 |
1 trial(s) available for homocysteine and Sepsis
| Article | Year |
|---|---|
Phase I study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor in patients with refractory solid tumors.
Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Deoxyuridine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Genotype; Glutarates; Homocysteine; Humans; Infusions, Intravenous; Isoindoles; Liposomes; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Polymorphism, Genetic; Quinazolines; Sepsis; Thymidylate Synthase; Time Factors; Treatment Outcome | 2005 |
7 other study(ies) available for homocysteine and Sepsis
| Article | Year |
|---|---|
Associations of Homocysteine, Procalcitonin, and D-Dimer Levels with Severity and Prognosis of Patients with Multiple Trauma.
Topics: APACHE; Fibrin Fibrinogen Degradation Products; Homocysteine; Humans; Multiple Trauma; Procalcitonin; Prognosis; ROC Curve; Sepsis | 2022 |
Methylation metabolism in sepsis and systemic inflammatory response syndrome.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; DNA Methylation; Female; Homocysteine; Humans; Male; Middle Aged; S-Adenosylhomocysteine; S-Adenosylmethionine; Sepsis; Systemic Inflammatory Response Syndrome; Young Adult | 2013 |
Homocysteine in dogs with systemic inflammatory response syndrome.
Topics: Animals; Case-Control Studies; Dog Diseases; Dogs; Female; Folic Acid; Homocysteine; Male; Sepsis; Systemic Inflammatory Response Syndrome; Vitamin B 12 | 2013 |
Methionine Metabolites in Patients With Sepsis.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Catheter-Related Infections; Cohort Studies; Female; Homocysteine; Hospital Mortality; Humans; Intraabdominal Infections; Logistic Models; Male; Methionine; Middle Aged; Prognosis; Prospective Studies; Respiratory Tract Infections; S-Adenosylhomocysteine; S-Adenosylmethionine; Sepsis; Skin Diseases, Infectious; Urinary Tract Infections | 2018 |
Antagonistic sepsis markers: Serum gelsolin and actin/gelsolin ratio.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Actins; Aged; Deoxyguanosine; Female; Gelsolin; Glutathione; Homocysteine; Humans; Male; Metabolic Syndrome; Middle Aged; Oxidative Stress; Sepsis | 2017 |
Methionine metabolism in an animal model of sepsis.
Topics: Animals; Cysteine; Disease Models, Animal; Glutathione; Homocysteine; Lipopolysaccharides; Male; Methionine; Oxidation-Reduction; Rats; S-Adenosylhomocysteine; S-Adenosylmethionine; Sepsis | 2008 |
The effect of homocysteine on the clinical outcomes of ventilated patients with severe sepsis.
Topics: Activated Protein C Resistance; Aged; Blood Coagulation Tests; Cohort Studies; Comorbidity; Factor V; Female; Folic Acid; Homocysteine; Homocystinuria; Hospital Mortality; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Muscle Spasticity; Point Mutation; Protein C; Psychotic Disorders; Respiration, Artificial; Sepsis; Shock, Septic; Thrombophilia; Vitamin B 12 | 2010 |